Fc gamma receptor polymorphisms and KRAS status as predictive biomarkers in patients with metastatic colorectal cancer treated with biweekly cetuximab-based salvage therapy. Background: A critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results